Episode 8: Outsmarting Opioids

Outsmarting Opioids

BY MATT BARRERA & BLANTON GILLESPIE

What types of treatments are available for opioid addiction and overdose? And, can chemists find a way to outsmart opioids to save lives? Tune in and dive into a neuropharmacological action adventure story!

This episode was produced as part of an upper level course on Neuropharmacology taught by Angel Kaur during Fall 2018 at UNC Asheville.


Articles Referenced

  • Lofwall, M. R, Walsh S. L, Nunes E. V.; JAMA Intern Med. , 2018, 178(6), 764-773. 
  • Nasser, A. F.; Greenwald, M. K.; Vince, B.; Fudala, P. J.; Twumasi-Ankrah, P.; Liu, Y.; Jones, J.; Heidbreder, C. Journal of Clinical Psychopharmacology, 2016, 36(1), 18-26.
  • Bickel, W. K.; Stitzer, M. L.; Bigelow, G. E.; Liebson, I. A.; Jasinski, D. R.; Johnson, R. E. Clinical Pharmacology and Therapeutics 1988, 43 (1), 72–78.
  • Bickel, W. K.; Stitzer, M. L.; Bigelow, G. E.; Liebson, I. A.; Jasinski, D. R.; Johnson, R. E. The J. of Pharm. and Experimental Therapeutics 1988, 247 (1), 47–53.
  • Campbell, N. D.; Lovell, A. M. Annals of the New York Academy of Sciences 2012, 1248 (1), 124–139.
  • Heel, R.; Brogden, R.; Speight, T.; Avery, G. Drugs 1979, 17 (2), 81–110.
  • Jacob, J.; Michaud, G.; Tremblay, E. British Journal of Clinical Pharmacology 1979, 7 (S3), 291–296.
  • Jasinski, D. R. Archives of General Psychiatry 1978, 35 (4), 501–516.
  • Jasinski, D. British Journal of Clinical Pharmacology 1979, 7 (S3), 287–290.
  • Johnson, R. E. Journal of the American Medical Association 1992, 267 (20), 2750–2755.
  • Kim, H. K.; Nelson, L. S. Expert Opinion on Drug Safety 2015, 14 (7), 1137–1146.
  • Mintzer, I. L.; Eisenberg, M.; Terra, M.; Macvane, C.; Himmelstein, D. U.; Woolhandler, S. The Annals of Family Medicine 2007, 5 (2), 146–150.
  • Rance, M. British Journal of Clinical Pharmacology 1979, 7 (S3), 281-286.
  • Understanding opioid dependence. https://www.suboxone.com/understanding-opioid-dependence (accessed Sep 19, 2018).
  • Wiegand, T. M. Journal of Medicinal Toxicology 2015. 12(1). 64-70
  • Al-Hasani, R.; Bruchas, M. R. Anesthesiology 2011, 115 (6), 1363-1381.
  • Galligan, J. J.; Akbarali, H. I. The Am. J. of Gastroenterology Supplements 2014, 2, 17-21.
  • Chahl, L. A. Experimental and Clinical Pharmacology: Opioids – mechanisms of action 1996, 19 (3), 63–65.
  • Chiang, C. N. Pharmacokinetics of the combination tablet of buprenorphine and naloxone 2003, 70(2), 39–47.
  • Dorp, E. V.; Yassen, A.; Sarton, E.; Romberg, R.; Olofsen, E.; Teppema, L.; Danhof, M.; Dahan, A. Naloxone Reversal of Buprenorphine-induced Respiratory Depression 2006, 105 (1), 51–57.
  • Ghelardini, C. The pharmacological basis of opioids 2015, 219–221.
  • Giglio, R. E.; Li, G.; Dimaggio, C. J. Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis 2015, 2 (1).
  • Ke, Y.-Y.; Huang, Y.-H.; Chien, W.-C.; Loh, H. H.; Chuang, J.-Y.; Yeh, S.-H. Mapping the naloxone binding sites on the mu-opioid receptor using cell-based photocrosslinkers 2017, 1865 (3), 336–343.
  • Kim, H. K.; Nelson, L. S. Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review 2015, 14 (7), 1137–1146.

Related Reading


Credits

Written, Directed, Edited, and Featuring: Blanton Gillespie and Matthew Barrera
Scientific Research by: Blanton Gillespie and Matthew Barrera


Episode Transcript
forthcoming

css.php